Verhoog L - Search Results

1

Optimization of Capture ELISAs for Chicken Cytokines Using Commercially Available Antibodies.

Krzysica P, Verhoog L, de Vries S, Smits C, Savelkoul HFJ, Tijhaar E. Krzysica P, et al. Among authors: verhoog l. Animals (Basel). 2022 Nov 4;12(21):3040. doi: 10.3390/ani12213040. Animals (Basel). 2022. PMID: 36359163 Free PMC article.

2

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets.

Yamamoto T, Ohashi-Doi K, Matsuhara H, Verhoog L, Lindholm M, Lawton S, Lund K. Yamamoto T, et al. Among authors: verhoog l. Curr Ther Res Clin Exp. 2022 Jun 23;96:100678. doi: 10.1016/j.curtheres.2022.100678. eCollection 2022. Curr Ther Res Clin Exp. 2022. PMID: 35813554 Free PMC article.

3

Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.

Van Bockstal MR, Cooks M, Nederlof I, Brinkhuis M, Dutman A, Koopmans M, Kooreman L, van der Vegt B, Verhoog L, Vreuls C, Westenend P, Kok M, van Diest PJ, Nauwelaers I, Laudus N, Denkert C, Rimm D, Siziopikou KP, Ely S, Zardavas D, Roberts M, Floris G, Hartman J, Acs B, Peeters D, Bartlett JMS, Dequeker E, Salgado R, Giudici F, Michiels S, Horlings H, van Deurzen CHM. Van Bockstal MR, et al. Among authors: verhoog l. Cancers (Basel). 2021 Sep 29;13(19):4910. doi: 10.3390/cancers13194910. Cancers (Basel). 2021. PMID: 34638394 Free PMC article.

4

Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer.

van Verschuer VM, Hooning MJ, van Baare-Georgieva RD, Hollestelle A, Timmermans AM, Koppert LB, Verhoog LC, Martens JW, Seynaeve C, van Deurzen CH. van Verschuer VM, et al. Among authors: verhoog lc. Hum Pathol. 2015 Feb;46(2):182-90. doi: 10.1016/j.humpath.2014.10.020. Epub 2014 Nov 15. Hum Pathol. 2015. PMID: 25522926

5

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

Hollestelle A, Peeters JK, Smid M, Timmermans M, Verhoog LC, Westenend PJ, Heine AA, Chan A, Sieuwerts AM, Wiemer EA, Klijn JG, van der Spek PJ, Foekens JA, Schutte M, den Bakker MA, Martens JW. Hollestelle A, et al. Among authors: verhoog lc. Breast Cancer Res Treat. 2013 Feb;138(1):47-57. doi: 10.1007/s10549-013-2415-3. Epub 2013 Jan 22. Breast Cancer Res Treat. 2013. PMID: 23338761

6

Molecular diagnostics of a single multifocal non-small cell lung cancer case using targeted next generation sequencing.

Geurts-Giele WR, Dirkx-van der Velden AW, Bartalits NM, Verhoog LC, Hanselaar WE, Dinjens WN. Geurts-Giele WR, et al. Among authors: verhoog lc. Virchows Arch. 2013 Feb;462(2):249-54. doi: 10.1007/s00428-012-1346-4. Epub 2012 Dec 22. Virchows Arch. 2013. PMID: 23262782

7

A Dutch patient presenting with a rare clinical syndrome. Cronkhite-Canada Syndrome.

Elshout G, Dor FJ, Verhoog LC, Berk L, Vrijland WW. Elshout G, et al. Among authors: verhoog lc. Gut. 2011 Sep;60(9):1213, 1253. doi: 10.1136/gut.2009.186080. Epub 2010 Jun 10. Gut. 2011. PMID: 20542864 No abstract available.

8

Should internal mammary chain (IMC) sentinel node biopsy be performed? Outcome in 90 consecutive non-biopsied patients with a positive IMC scintigraphy.

Wouters MW, van Geel AN, Menke-Pluijmers M, de Kanter AY, de Bruin HG, Verhoog L, Eggermont AM. Wouters MW, et al. Among authors: verhoog l. Breast. 2008 Apr;17(2):152-8. doi: 10.1016/j.breast.2007.08.005. Epub 2007 Sep 24. Breast. 2008. PMID: 17890088

9

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

Seynaeve C, Verhoog LC, van de Bosch LM, van Geel AN, Menke-Pluymers M, Meijers-Heijboer EJ, van den Ouweland AM, Wagner A, Creutzberg CL, Niermeijer MF, Klijn JG, Brekelmans CT. Seynaeve C, et al. Among authors: verhoog lc. Eur J Cancer. 2004 May;40(8):1150-8. doi: 10.1016/j.ejca.2004.01.017. Eur J Cancer. 2004. PMID: 15110878

10

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF. Lodder L, et al. Among authors: verhoog lc. Am J Med Genet A. 2003 Jun 15;119A(3):266-72. doi: 10.1002/ajmg.a.10168. Am J Med Genet A. 2003. PMID: 12784290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page